Orlando, Fla.—Left ventricular assist device (LVAD) therapy is associated with substantial postimplantation morbidity and mortality, a study has confirmed. Readmissions after LVAD implantation are commonplace and often due to gastrointestinal bleeding, device malfunction and/or heart failure.
“Although LVAD has been the focus of significant research, most studies have looked at mortality,” said Atul Gupta, MBBS, clinical associate in the Department of Anesthesia at the